Melphalan |
Chemotherapy drug |
Bone marrow damage and chemotherapy side effects |
Bergsagel et al. (1962)
|
Thalidomide (Thalomid) |
Immunomodulating agent |
Drowsiness, fatigue, constipation, and painful nerve damage as well as severe birth defects when taken during pregnancy |
Singhal et al. (1999)
|
Bortezomib (Velcade) |
Proteasome inhibitor |
Vomiting, tiredness, diarrhea, constipation, decreased appetite, fever, lowered blood counts and nerve damage |
Richardson et al. (2003)
|
Lenalidomide (Revlimid) |
Small molecule analogue of thalidomide |
Drowsiness, fatigue, constipation, and painful nerve damage as well as severe birth defects when taken during pregnancy |
Hideshima et al. (2000), Rajkumar et al. (2005), Richardson et al. (2002)
|
Carfilzomib (Kyprolis) |
Proteasome inhibitor |
Tiredness, nausea, vomiting, diarrhea, shortness of breath, fever and low blood counts and occasionally more serious problems such as pneumonia, heart problems, and kidney or liver failure |
Herndon et al. (2013)
|
Pomalidomide (Pomalyst) |
Small molecule analogue of thalidomide |
Same thalidomide side effects with a less risk of nerve damage side effect |
Lacy et al. (2009)
|
Panobinostat (Farydak) |
Oral Histone deacetylase (HDAC) inhibitor |
Feeling tired, weakness, nausea, diarrhea vomiting, loss of appetite, fever, swelling in the arms or legs, and occasionally altered blood cell counts and blood electrolytes. Rare cases of internal bleeding, liver damage, and changes in heart rhythm which can sometimes be life threatening |
Laubach et al. (2015)
|
Ixazomib (Ninlaro) |
Oral proteasome inhibitor |
Nausea, vomiting, diarrhea, constipation, swelling in the hands or feet, back pain, lowered blood platelet count and nerve damage |
Muz et al. (2016)
|
Daratumumab (Darzalex) |
Intravenous monoclonal antibody |
Coughing, wheezing, trouble breathing, throat tightness, runny nose, nasal congestion, feeling dizzy or lightheaded, headache, rash, nausea, fatigue, back pain, fever, and lower blood cell counts |
Lokhorst et al. (2015)
|
Elotuzumab (Empliciti) |
Intravenous monoclonal antibody |
Chills, feeling dizzy or lightheaded, wheezing, trouble breathing, cough, tightness in the throat, runny nose, nasal congestion, upper respiratory tract infections and pneumonia, rash, fatigue, loss of appetite, diarrhea, constipation, fever, and nerve damage |
Lonial et al. (2015)
|
Selinexor (Xpovio) |
Oral Nuclear export inhibitor of XPO1 |
Diarrhea, nausea, vomiting, loss of appetite, weight loss, low blood sodium levels susceptibility to infection, low platelet counts, and low white blood cell counts |
Vogl et al. (2018)
|